Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 12 open reading frame 60 (C12orf60) is a human gene encoding an uncharacterized protein, also referred to as LOC144608 or MGC47869, consisting of 245 amino acids and predicted to localize predominantly in the nucleus. The protein lacks transmembrane domains and is rich in alpha-helices, containing a conserved domain of unknown function (DUF4533, pfam15047) shared with very few other gene products. C12orf60 displays regulated expression in human tissues, with highest levels seen in testes and colon, as well as presence in the kidney, certain brain regions, and breast carcinomas. Its biological role remains poorly defined, although protein–protein interaction data suggest possible interactions with bone morphogenetic protein 4 (BMP4) and other proteins, without consensus on functional implications. In the literature, C12orf60 has been identified as a candidate biomarker for monitoring allergen immunotherapy response but is not established as a therapeutic target or drug receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 12 open reading frame 60 (C12orf60).